Frequently Asked Questions AOD9604 6mg is used in controlled in-vitro studies focusing on cellular signaling pathways, metabolic research, receptor binding, and proteinpeptide interaction analysis
Therefore, the support for its therapeutic uses is limited, albeit largely optimistic
Furthermore, because antibodies to sermorelin can develop, if theres any sign that the medication isnt working as expected (for instance, IGF-1 stops rising despite dose increases), the doctor might investigate if neutralizing antibodies are a factor
M1 microglia release inflammatory mediators that can worsen neuronal injury
Following a 15-min incubation, samples were analyzed either on the Fortessa LSRII system using FACS Diva 6.1.1 software (BD Biosciences) or on the Symphony A3 system with FACS Diva v9.0 software (BD Biosciences)